Trial Radar
Sign in

NCT lookup

Pull any trial record directly from ClinicalTrials.gov.

Post-Market Clinical Follow-Up Study on the Safety and Performance of Ennovate® Cervical
Post-Market Clinical Follow-Up Study on the Safety and Performance of Ennovate® Cervical

NCT05296889

RecruitingN/A

Sponsor: Aesculap AG

Conditions: Spine Fracture, Degenerative Disc Disease, Spinal Instability, Spinal Tumor, Degenerative Myelopathy

Interventions: posterior stabilization for the cervical spine

Countries: Germany

Multicenter Post market clinical follow-up Study on the Safety and Performance of Ennovate® Cervical - Prospective, pure data collection of all Ennovate Cervical patients in Total Indications

Eligibility overview

Sex: ALL

Age: 18 Years to —

Healthy volunteers: No

Study type: OBSERVATIONAL

Eligibility criteria
Inclusion Criteria:

* Patient is minimum 18 years old
* Informed Consent in the documentation of clinical and radiological results
* Patient has indication according to Instructions for Use (IFU)
* Patient is not pregnant

Exclusion Criteria:

* Patient's clear unability or unwillingness to participate in follow-up examinations
Locations (4)
  • Hamburg, Free and Hanseatic City of Hamburg, Germany
  • Meppen, Lower Saxony, Germany
  • Dresden, Saxony, Germany
  • Halle, Saxony-Anhalt, Germany